MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

BM-1197

CAS No. : 1391107-89-3

MCE 国际站：BM-1197

产品活性：BM-1197 是一种有效的和选择性的 Bcl-2/Bcl-xL 的双重抑制剂，抑制 Bcl-2 和 Bcl-xL 的 IC₅₀ 值分别为 3.5 nM 和 5.2 nM。BM-1197 在体外和体内均表现出抗肿瘤作用。

研究领域：Apoptosis

作用靶点：Bcl-2 Family

In Vitro: BM-1197 (2-2000 nM; 3 d) has marginal cytotoxicity against wild-type mouse embryonic fibroblast (MEF) cells but exerts potent growth-inhibitory activity in the MCL1^−/− cells.
BM-1197 shows potent growth-inhibitory activities in 7 small cell lung cancer (SCLC) cell lines with IC₅₀s <100 nM, moderate activity in 3 SCLC cell lines with IC₅₀s of ∼600 nM and weak activity in 2 SCLC cell lines with IC₅₀s >2000 nM.
BM-1197 (100 nM; 16 h) potently induces apoptosis in H146 cells.
BM-1197 (100 nM; 2 h) disrupts the association between Bcl-xl and Puma or Bim in H146 cells.
BM-1197 (100 nM; 0.5-2 h) induces Bax translocation, and it (3-30 nM; 2 h) induces cytochrome c release in H146 cells.

In Vivo: BM-1197 (10 mg/kg; i.v. daily 5 days per week for 2 weeks) results in rapid and complete tumor regression in all 8 mice in H146 and H1963 tumor model.
BM-1197 (15 mg/kg; i.v.) causes thrombocytopenia in mice but the effect is reversible even at highly efficacious doses.
BM-1197 (10 mg/kg; i.v. qd) exerts a strong anti-tumor effect and is well tolerated in OCI-Ly8 xenograft models.

相关产品：Venetoclax | BT2 | Chelerythrine chloride | Bax inhibitor peptide V5 | A-1210477 | BAI1 | Dehydrocorydaline chloride | Gambogic Acid | Gossypol | BI-3812 | Clitocine | PROTAC Bcl2 degrader-1 | (R)-(-)-Gossypol acetic acid | MIM1 | TW-37 | (E)-Ferulic acid | Jaceosidin | Paris saponin VII | Bz 423 | Dihydrokaempferol | MSN-125 | HA14-1 | TCPOBOP | BH3I-1 | Thevetiaflavone

品牌介绍:
• MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供最新最全的高品质小分子活性化合物；
• 10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
• 设有专业的实验中心和严格的质控、验证体系；
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
• 产品的生物活性多经各国客户实验验证；
• Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；
• 专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；
• 与世界各大制药公司及知名科研机构建立了长期的合作。